tickrz reports
Edwards Lifesciences Corp (EW)
Healthcare | Health Services
118.02  -0.01%
EW vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
EWSECTORS&P 500
P/E RATIO34.2631.120.18
EV/EBITDA RATIO24.7117.412.15
P/S RATIO7.73.72.14
P/B RATIO8.075.53.29
QUALITY
RETURN ON EQUITY25.45%14.19%13.65%
RETURN ON CAPITAL38.78%20.54%10.09%
NET MARGIN19.22%8.82%9.76%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0%
PAYOUT RATION/A
3 YR DIVIDEND GROWTHN/A
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY34%
INTEREST COVERAGE179.3x
CURRENT RATIO3.49
GROWTH
5 YR EPS GROWTH21.4%
5 YR SPS GROWTH12.04%
5 YR BPS GROWTH16.12%
Edwards Lifesciences Corp News
See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
Edwards Lifesciences Corp NYSE:EW
December 08, 13:04:22 UTC

[$$] Harpoon Medical Acquired by Edwards Lifesciences
Venture-backed medical-device startup Harpoon Medical Inc. has been acquired by Edwards Lifesciences for up to $250 million in cash and milestones.
December 07, 23:06:22 UTC

Sage Therapeutics, Dollar General jump; LendingClub tumbles
Stocks that moved substantially or traded heavily Thursday: Sage Therapeutics Inc., up $64.37 to $156.27 The drug developer said a depression drug worked in a clinical study, its second success in about ...
December 07, 21:24:20 UTC

S&P 500 Movers: HRB, VIAB
In early trading on Thursday shares of Viacom VIAB topped the list of the day s best performing components of the S amp P 500 index trading up 4 1 Year to date Viacom has lost about 14 2 of its value And the worst performing S amp P 500 component thus far on the day is H amp
December 07, 17:15:38 UTC

Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio
Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.
December 07, 13:16:01 UTC

Edwards Lifesciences sets $1 billion stock buyback program, gives 2018 guidance
Edwards Lifesciences Corp. said Thursday it authorized a new $1 billion stock repurchase program. At Wednesday's stock closing price of $113.36, the program could represent about 4.2% of the shares outstanding. ...
December 07, 12:36:23 UTC

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program
Company Also Enters Into Accelerated Share Repurchase Agreement NEW YORK , Dec. 7, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for ...
December 07, 12:01:00 UTC

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
NEW YORK , Dec. 7, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss ...
December 07, 12:00:00 UTC

Edwards Lifesciences Backs FY17 View, Sees Higher FY18; To Buy Back $1 Bln Share
Edwards Lifesciences Backs FY17 View, Sees Higher FY18; To Buy Back $1 Bln Share
December 07, 07:24:00 UTC

MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today
MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today
December 07, 01:58:00 UTC

Edwards Acquires Harpoon Medical
IRVINE, Calif., Dec. 6, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR).  Edwards announced a structured upfront investment in Harpoon in 2015, with an exclusive option to acquire the company. Under the terms of the merger agreement, Edwards paid $100 million in cash for Harpoon at closing on Dec. 1.  In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.
December 06, 21:30:00 UTC

Northern Technologies International Corporation (NTIC) Ex-Dividend Date Scheduled for December 07, 2017
Northern Technologies International Corporation NTIC will begin trading ex dividend on December 07 2017 A cash dividend payment of 0 1 per share is scheduled to be paid on December 21 2017 Shareholders who purchased NTIC prior to the ex dividend date are eligible for the cash
December 06, 14:30:36 UTC

See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
Edwards Lifesciences Corp NYSE:EW
December 06, 13:03:34 UTC

Top Biotech Stock Near Buy Zone, Shows Positive Drug Trial Results
On Monday leading drugmaker AbbVie ABBV announced positive Phase 3 trial results for its psoriasis treatment risankizumab On Tuesday the IBD Big Cap 20 160 was up fractionally and within 3 of a potential new buy zone ibd display video id 2102289 width
December 05, 22:12:49 UTC

ETFs with exposure to Edwards Lifesciences Corp. : December 5, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Edwards Lifesciences Corp. Here are 5 ETFs with the largest exposure to EW-US. Comparing the performance and risk of Edwards Lifesciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
December 05, 17:46:56 UTC


Edwards Lifesciences Corp (EW)
Healthcare | Health Services
118.02  -0.01%

See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
Edwards Lifesciences Corp NYSE:EW
December 08, 13:04:22 UTC

[$$] Harpoon Medical Acquired by Edwards Lifesciences
Venture-backed medical-device startup Harpoon Medical Inc. has been acquired by Edwards Lifesciences for up to $250 million in cash and milestones.
December 07, 23:06:22 UTC

Sage Therapeutics, Dollar General jump; LendingClub tumbles
Stocks that moved substantially or traded heavily Thursday: Sage Therapeutics Inc., up $64.37 to $156.27 The drug developer said a depression drug worked in a clinical study, its second success in about ...
December 07, 21:24:20 UTC

S&P 500 Movers: HRB, VIAB
In early trading on Thursday shares of Viacom VIAB topped the list of the day s best performing components of the S amp P 500 index trading up 4 1 Year to date Viacom has lost about 14 2 of its value And the worst performing S amp P 500 component thus far on the day is H amp
December 07, 17:15:38 UTC

Edwards Lifesciences Buys Harpoon Medical, Expands Portfolio
Edwards Lifesciences (EW) expands Surgical Heart Valve Therapy segment with the buyout of Harpoon Medical.
December 07, 13:16:01 UTC

Edwards Lifesciences sets $1 billion stock buyback program, gives 2018 guidance
Edwards Lifesciences Corp. said Thursday it authorized a new $1 billion stock repurchase program. At Wednesday's stock closing price of $113.36, the program could represent about 4.2% of the shares outstanding. ...
December 07, 12:36:23 UTC

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program
Company Also Enters Into Accelerated Share Repurchase Agreement NEW YORK , Dec. 7, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for ...
December 07, 12:01:00 UTC

Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
NEW YORK , Dec. 7, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, will discuss ...
December 07, 12:00:00 UTC

Edwards Lifesciences Backs FY17 View, Sees Higher FY18; To Buy Back $1 Bln Share
Edwards Lifesciences Backs FY17 View, Sees Higher FY18; To Buy Back $1 Bln Share
December 07, 07:24:00 UTC

MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today
MDGL Crossed $100 Mark, INSY Awaits FDA Decision In July, ODT IPO Today
December 07, 01:58:00 UTC

Edwards Acquires Harpoon Medical
IRVINE, Calif., Dec. 6, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company pioneering beating-heart repair for degenerative mitral regurgitation (DMR).  Edwards announced a structured upfront investment in Harpoon in 2015, with an exclusive option to acquire the company. Under the terms of the merger agreement, Edwards paid $100 million in cash for Harpoon at closing on Dec. 1.  In addition, there is the potential for up to $150 million in pre-specified milestone-driven payments over the next 10 years.
December 06, 21:30:00 UTC

Northern Technologies International Corporation (NTIC) Ex-Dividend Date Scheduled for December 07, 2017
Northern Technologies International Corporation NTIC will begin trading ex dividend on December 07 2017 A cash dividend payment of 0 1 per share is scheduled to be paid on December 21 2017 Shareholders who purchased NTIC prior to the ex dividend date are eligible for the cash
December 06, 14:30:36 UTC

See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
Edwards Lifesciences Corp NYSE:EW
December 06, 13:03:34 UTC

Top Biotech Stock Near Buy Zone, Shows Positive Drug Trial Results
On Monday leading drugmaker AbbVie ABBV announced positive Phase 3 trial results for its psoriasis treatment risankizumab On Tuesday the IBD Big Cap 20 160 was up fractionally and within 3 of a potential new buy zone ibd display video id 2102289 width
December 05, 22:12:49 UTC

ETFs with exposure to Edwards Lifesciences Corp. : December 5, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Edwards Lifesciences Corp. Here are 5 ETFs with the largest exposure to EW-US. Comparing the performance and risk of Edwards Lifesciences Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
December 05, 17:46:56 UTC